1.1 This guide provides an overview to the risk-based validation of process analytical methods under a process analytical technology (PAT) paradigm for pharmaceuticals and biopharmaceuticals and as such includes guidance on assessing risk to product quality from inappropriate method validation.
Product Details
Published:
05/15/2020
Number of Pages:
7
File Size:
1 file , 110 KB
Redline File Size:
2 files , 230 KB
Note:
This product is unavailable in Russia, Ukraine, Belarus
